Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - amiloride hydrochloride - oral solution - amiloride hydrochloride 5.675 mg - diuretics

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - amiloride hydrochloride dihydrate 5mg - tablet - 5 mg - active: amiloride hydrochloride dihydrate 5mg

New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - amiloride hydrochloride dihydrate 5.7mg equivalent to amiloride hydrochloride 5 mg - tablet - 5 mg - active: amiloride hydrochloride dihydrate 5.7mg equivalent to amiloride hydrochloride 5 mg excipient: croscarmellose sodium iron oxide yellow lactose monohydrate magnesium stearate microcrystalline cellulose - indicated as concomitant therapy with diuretics to conserve potassium during periods of vigorous diuresis and during long-term maintenance therapy with thiazides or other more potent diuretics. apo-amiloride when used alone has mild diuretic and antihypertensive activity.

Namibia - English - Namibia Medicines Regulatory Council

specpharm (pty) ltd - amiloride hcl; hydrochlorothiazide - tablet - each tablet contains amiloride hydrochloride 5 mg and hydrochlorothiazide 50 mg

Canada - English - Health Canada

pentapharm ltd. - amiloride hydrochloride; hydrochlorothiazide - tablet - 5mg; 50mg - amiloride hydrochloride 5mg; hydrochlorothiazide 50mg - potassium-sparing diuretics

Zimbabwe - English - Medicines Control Authority

datlabs private limited - amiloride hydrochloride; hydrochlorothiazide - tablet; oral - 50; 5mg

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - amiloride hydrochloride dihydrate, quantity: 5 mg - tablet, uncoated - excipient ingredients: maize starch; povidone; lactose monohydrate; microcrystalline cellulose; magnesium stearate - indications as at 15 july 1998 : kaluril's main indication is as concomitant therapy with diuretics to conserve potassium during periods of vigorous diuresis and during long-term maintenance therapy with thiazides or other more potent diuretics. kaluril when used alone, has mild diuretic and antihypertensive activity. oedema of cardiac origin. although kaluril alone may provide adequate diuresis for some patients with oedema of cardiac origin, it is primarily indicated for concomitant use in patients receiving thiazides or more potent saluretic diuretic agents. in these patients it may provide increased sodium, chloride and water excretion and decreased potassium excretion. the positive effect of kaluril on potassium balance may be especially important for digitalised cardiac patients, in whom potassium depletion sensitises or exaggerates the response of the heart to the toxic effects of digitalis (e.g. increased ventricular irritability), which may precipitate digitalis intoxication with potentially seriou

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - amiloride hydrochloride - oral solution - 1mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - amiloride hydrochloride - oral solution - 100microgram/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - amiloride hydrochloride - oral suspension - 100microgram/1ml